QLT Inc.

218 articles with QLT Inc.

• QLT Inc. Announces First Quarter 2012 Results

  5/3/2012

• QLT Inc. to Report First Quarter Financial Results on May 3, 2012

  4/19/2012

• QLT Inc. Announces the Appointment of Christopher Muller as Chief Commercial Officer

  4/16/2012

• QLT Inc. Announces QLT091001 Presentation at Association for Research in Vision & Ophthalmology

  4/2/2012

• QLT Inc. Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy

  3/19/2012

• QLT Inc. to Present at ROTH Capital Partners Annual Growth Stock Conference

  3/8/2012

• QLT Inc. to Present at the 2012 RBC Capital Markets' Global Healthcare Conference

  2/24/2012

• QLT Inc. Announces Fourth Quarter and Year End 2011 Results

  2/23/2012

• QLT Inc. to Present at the Leerink Swann and Company 2012 Global Healthcare Conference

  2/8/2012

• QLT Inc. to Present at the J.P. Morgan Healthcare Conference

  1/9/2012

• QLT Inc. to Host Research and Development Day in New York City on December 16, 2011

  12/8/2011

• QLT Inc. Announces Third Quarter Results for 2011

  11/3/2011

• QLT Inc. to Report Third Quarter Financial Results on November 3, 2011

  10/26/2011

• QLT Inc. to Present at the UBS Global Life Sciences Conference

  9/19/2011

• QLT Inc. Receives Fast Track Designations for QLT091001 to Treat Both Leber Congenital Amaurosis and Retinitis Pigmentosa

  9/14/2011

• QLT Inc. Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System

  8/29/2011

• QLT Inc. Announces Second Quarter Results for 2011

  7/28/2011

• QLT Inc. Announces First Quarter Results for 2011

  5/5/2011

• QLT Inc. Announces Positive Results From Phase 1b Trial of QLT091001 in Subjects With Leber Congenital Amaurosis

  5/3/2011

• QLT Inc. Announces QLT091001 Presentation At ARVO

  4/27/2011